News | July 24, 2024
Syngene reports drop in Q1 FY25 revenue to Rs. 790 Cr
Reported profit after tax declined 19% year-on-year to Rs 76 crores
Reported profit after tax declined 19% year-on-year to Rs 76 crores
Acquisition strengthens and diversifies Merck’s pipeline with the addition of Restoret
The My Green Lab Certification is the gold standard for laboratory sustainability practices worldwide
Felzartamab demonstrated positive interim results from the Phase 2 IgA nephropathy (IgAN) study
Zealand Pharma anticipates initiation of a Phase 2b clinical trial in H2 2024
Abdel has held leadership positions at Bayer, Merck, Catalent, Lonza, and KBI Biopharma,
Co-founder and previous CEO Lowry Curley becomes Chief Scientific Officer
Accelerating sustainability in Indian pharma industry
Oligonucleotides are a unique modality with potential to address hard-to-treat diseases with high unmet need
The state-of-the-art facility is equipped with best-in-class equipment and control systems
Subscribe To Our Newsletter & Stay Updated
